Начало・Списък с акции・Elanco Animal Health Inc

Elanco Animal Health Inc

Отворен

СекторЗдравеопазване

25.56 -0.47

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

25.26

Максимум

25.82

Ключови измерители
By Trading Economics
Приходи	289M 57M
Продажби	227M 1.4B
P/E Средно за сектора	372.714 64.641
EPS	0.4
Марж на печалбата	4.158
Служители	9,400
EBITDA	310M 316M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+17.19% upside

Дивиденти
By Acuity
Следващи печалби	5.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	1.4B 13B
Предишно отваряне	26.03
Предишно затваряне	25.56

Настроения в новините

By Acuity

40%

60%

128 / 340 Класиране в Healthcare

Elanco Animal Health Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.08.2026 г., 20:02 ч. UTC

Elanco Animal Health is trading lower amid a broader market decline, reflecting negative sentiment in the pharmaceuticals sector. No specific news was identified.

31.07.2026 г., 23:01 ч. UTC

Elanco Animal Health Inc shares are lower in after-market hours, trading near the lower end of their one-month range with no specific news identified.

30.07.2026 г., 16:11 ч. UTC

Elanco Animal Health is lower today, influenced by declines in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

29.07.2026 г., 18:14 ч. UTC

Elanco Animal Health shares are higher today, breaking a pattern of recent daily closes. No specific news was identified to explain the movement.

28.07.2026 г., 18:26 ч. UTC

Correlated Moves

News

Bank of America maintains its buy rating on Elanco Animal Health, citing a favorable catalyst profile ahead of second-quarter earnings. Shares are higher today.

27.07.2026 г., 18:36 ч. UTC

Elanco Animal Health is trading higher, reflecting positive market conditions, though no specific news was identified to explain the price movement.

24.07.2026 г., 19:26 ч. UTC

Elanco Animal Health shares are higher, reflecting broader market dynamics amid a pullback in crude oil prices and easing energy-related pressures.

23.07.2026 г., 10:16 ч. UTC

Elanco Animal Health is trading roughly flat in pre-market hours, despite broader market declines influenced by earnings reports and rising oil prices.

22.07.2026 г., 19:25 ч. UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21.07.2026 г., 19:26 ч. UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20.07.2026 г., 19:46 ч. UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Сравнение с други в отрасъла

Ценова промяна

Elanco Animal Health Inc Прогноза

Ценова цел

By TipRanks

17.19% нагоре

12-месечна прогноза

Среден 30.14 USD 17.19%

Висок 32 USD

Нисък 26 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за Elanco Animal Health Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

Купи

Задържане

Продай

Според 11 анализатори, дали борсови рейтинги на Elanco Animal Health Inc през последните 3 месеца.

Настроение

By Acuity

128 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.